HEPAGAM B

This brand name is authorized in Canada, Israel, Turkey, United States

Active ingredients

The drug HEPAGAM B contains one active pharmaceutical ingredient (API):

1 Human hepatitis B immunoglobulin UNII XII270YC6M - HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN

Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure. Read about Human hepatitis B immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HEPAGAM B Solution for infusion	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BB04	Hepatitis B immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02290979
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7449
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699733980059, 8699733980073
Country: US	FDA, National Drug Code	Identifier(s): 70257-051, 70257-052, 70257-053, 70257-054, 70504-0051, 70504-0052, 70504-0053, 70504-0054